Skip to main content

GE Healthcare Will Exclusively Distribute Dharmacon s RNAi Products in Japan

NEW YORK, Nov. 22 (GenomeWeb News) - GE Healthcare will be the exclusive distributor of RNAi research products for Dharmacon in Japan, the companies said today.

 

Customers in Japanwill be able to order Dharmacon products directly from GE Healthcare. GE's sales and technical staff will be trained to support Dharmacon's RNAi product line.

 

Dharmacon, a subsidiary of Fischer Scientific International, is based in Lafayette, Colo.

The Scan

Possibly as Transmissible

Officials in the UK say the B.1.617.2 variant of SARS-CoV-2 may be as transmitted as easily as the B.1.1.7 variant that was identified in the UK, New Scientist reports.

Gene Therapy for SCID 'Encouraging'

The Associated Press reports that a gene therapy appears to be effective in treating severe combined immunodeficiency syndrome.

To Watch the Variants

Scientists told US lawmakers that SARS-CoV-2 variants need to be better monitored, the New York Times reports.

Nature Papers Present Nautilus Genome, Tool to Analyze Single-Cell Data, More

In Nature this week: nautilus genome gives peek into its evolution, computational tool to analyze single-cell ATAC-seq data, and more.